BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 19896699)

  • 1. Overexpression of A disintegrin and metalloproteinase 28 is correlated with high histologic grade in conventional chondrosarcoma.
    Matsuura S; Oda Y; Matono H; Izumi T; Yamamoto H; Tamiya S; Iwamoto Y; Tsuneyoshi M
    Hum Pathol; 2010 Mar; 41(3):343-51. PubMed ID: 19896699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased expression of matrilin-3 not only in osteoarthritic articular cartilage but also in cartilage-forming tumors, and down-regulation of SOX9 via epidermal growth factor domain 1-dependent signaling.
    Vincourt JB; Vignaud JM; Lionneton F; Sirveaux F; Kawaki H; Marchal S; Lomazzi S; Plénat F; Guillemin F; Netter P; Takigawa M; Mainard D; Magdalou J
    Arthritis Rheum; 2008 Sep; 58(9):2798-808. PubMed ID: 18759284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular analysis of the INK4A/INK4A-ARF gene locus in conventional (central) chondrosarcomas and enchondromas: indication of an important gene for tumour progression.
    van Beerendonk HM; Rozeman LB; Taminiau AH; Sciot R; Bovée JV; Cleton-Jansen AM; Hogendoorn PC
    J Pathol; 2004 Mar; 202(3):359-66. PubMed ID: 14991902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. cDNA expression profiling of chondrosarcomas: Ollier disease resembles solitary tumours and alteration in genes coding for components of energy metabolism occurs with increasing grade.
    Rozeman LB; Hameetman L; van Wezel T; Taminiau AH; Cleton-Jansen AM; Hogendoorn PC; Bovée JV
    J Pathol; 2005 Sep; 207(1):61-71. PubMed ID: 16007578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endogenous secretory receptor for advanced glycation endproducts as a novel prognostic marker in chondrosarcoma.
    Takeuchi A; Yamamoto Y; Tsuneyama K; Cheng C; Yonekura H; Watanabe T; Shimizu K; Tomita K; Yamamoto H; Tsuchiya H
    Cancer; 2007 Jun; 109(12):2532-40. PubMed ID: 17497647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Minichromosome maintenance protein (MCM6) in low-grade chondrosarcoma: distinction from enchondroma and identification of progressive tumors.
    Helfenstein A; Frahm SO; Krams M; Drescher W; Parwaresch R; Hassenpflug J
    Am J Clin Pathol; 2004 Dec; 122(6):912-8. PubMed ID: 15539383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transforming growth factor-beta isoform and receptor expression in chondrosarcoma of bone.
    Masi L; Malentacchi C; Campanacci D; Franchi A
    Virchows Arch; 2002 May; 440(5):491-7. PubMed ID: 12021923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of interobserver variability and histologic parameters to improve reliability in classification and grading of central cartilaginous tumors.
    Eefting D; Schrage YM; Geirnaerdt MJ; Le Cessie S; Taminiau AH; Bovée JV; Hogendoorn PC;
    Am J Surg Pathol; 2009 Jan; 33(1):50-7. PubMed ID: 18852676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical expression of estrogen receptors in chondrosarcomas and enchondromas.
    Grifone TJ; Haupt HM; Podolski V; Brooks JJ
    Int J Surg Pathol; 2008 Jan; 16(1):31-7. PubMed ID: 18203781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of cytofluorometric DNA ploidy analysis in distinguishing benign cartilaginous tumors from chondrosarcomas.
    Kusuzaki K; Murata H; Takeshita H; Hirata M; Hashiguchi S; Tsuji Y; Nakamura S; Ashihara T; Hirasawa Y
    Mod Pathol; 1999 Sep; 12(9):863-72. PubMed ID: 10496594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absence of IHH and retention of PTHrP signalling in enchondromas and central chondrosarcomas.
    Rozeman LB; Hameetman L; Cleton-Jansen AM; Taminiau AH; Hogendoorn PC; Bovée JV
    J Pathol; 2005 Mar; 205(4):476-82. PubMed ID: 15685701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of leukemia inhibitory factor by cartilage-forming tumors of bone: an immunohistochemical study.
    Gouin F; Moreau A; Couillaud S; Guicheux J; Passuti N; Godard A; Heymann D
    J Orthop Res; 1999 Mar; 17(2):301-5. PubMed ID: 10221849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ADAMTS1 is regulated by interleukin-1beta, not by hypoxia, in chondrosarcoma.
    Kalinski T; Krueger S; Sel S; Werner K; Röpke M; Roessner A
    Hum Pathol; 2007 Jan; 38(1):86-94. PubMed ID: 16949904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary.
    Sakata K; Shigemasa K; Nagai N; Ohama K
    Int J Oncol; 2000 Oct; 17(4):673-81. PubMed ID: 10995877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PTHrP and Bcl-2: essential regulatory molecules in chondrocyte differentiation and chondrogenic tumors.
    Amling M; Pösl M; Hentz MW; Priemel M; Delling G
    Verh Dtsch Ges Pathol; 1998; 82():160-9. PubMed ID: 10095428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Matrix gene expression pattern as indicators of the biology of cartilage-forming tumors].
    Aigner T; Unni CC; Bjornsson J; Kirchner T
    Verh Dtsch Ges Pathol; 1998; 82():178-83. PubMed ID: 10095430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunolocalization of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human chondrosarcomas.
    Kawashima A; Okada Y; Nakanishi I; Ueda Y; Iwata K; Roessner A
    Gen Diagn Pathol; 1997 Feb; 142(3-4):129-37. PubMed ID: 9065576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential expression of VEGF-A and angiopoietins in cartilage tumors and regulation by interleukin-1beta.
    Kalinski T; Krueger S; Sel S; Werner K; Ropke M; Roessner A
    Cancer; 2006 May; 106(9):2028-38. PubMed ID: 16565972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of membrane type 1 matrix metalloproteinase, matrix metalloproteinase 2 and tissue inhibitor of metalloproteinase 2 in human cartilaginous tumors with special emphasis on mesenchymal and dedifferentiated chondrosarcoma.
    Sakamoto A; Oda Y; Iwamoto Y; Tsuneyoshi M
    J Cancer Res Clin Oncol; 1999 Oct; 125(10):541-8. PubMed ID: 10473866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PAS inclusions, immunoreactive tenascin and proliferative activity in low-grade chondrosarcomas.
    Ranty ML; Michot C; Le Pessot F; Hellot MF; Biga N; Dujardin FH; Simonet J; Billerey C; Metayer J
    Pathol Res Pract; 2003; 199(1):29-34. PubMed ID: 12650515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.